27 March 2016: Together with Rich Tree Holdings, AAMG broke ground on the Zhuhai-Singapore Life Science Park; will bring world-class wellness and advanced diagnostic services to Southern China when it opens in 2018.

1. Page 1 of 3
Singapore-Based Asian American Medical Group and Rich Tree Holdings
Break Ground on Zhuhai-Singapore Life Science Park;
Advanced Diagnostic and Wellness Medical Centre Will Bring
World-Class Services to Southern China in 2018
Singapore/ Zhuhai, 27 March 2016 – Leading Singapore-based healthcare operator Asian
American Medical Group Limited (“AAMG”), together with private equity firm Rich Tree
Holdings (“RTH”), broke ground today on the Zhuhai-Singapore Life Science Park (the “Park”),
which will bring world-class wellness and advanced diagnostic services to Southern China
when it opens in 2018.
The specialist ambulatory medical centre will offer health screening, endoscopic and
operation services, as well as multidisciplinary medical consultations including a one-stop
suite of aesthetic services. Together with its U.S. based healthcare partner, UPMC, AAMG will
oversee the design and delivery of the US$59 million centre.
This project is expected to reshape Asian medical tourism over the next decade, leveraging
China’s strong demand for world-class medical expertise. The Park is scheduled to come on
stream at the time of the completion of the Hong Kong-Zhuhai-Macau Bridge, a series of
connected bridges and tunnels to facilitate easy access between the three major cities, in
2017.
Beyond medical services, the Park will also feature modern amenities such as an international
health screening centre, multi-disciplinary medical suites, and several retail and F&B outlets.
Headquartered in Singapore’s Gleneagles Hospital and listed on the Australian Securities
Exchange, AAMG will bring together renowned specialist medical groups from Korea,
Singapore and the U.S. to operate in the Park.
AAMG is finalising the completion of its acquisition of 60% stake in Rich Tree Land Pte. Ltd.
(“RTL”), the Singapore-incorporated SPV which had secured the 5,446.14 square meter
(“sqm”) land parcel in the Zhuhai Free Trade Zone (“FTZ”). The 17-storey medical centre will
have a built-up area of 21,784.56 sqm (based on approved plot ratio of 4.0).
AAMG’s Executive Chairman, Dr. Tan Kai Chah, said, “Today’s groundbreaking marks the
beginning of our venture in China, which would not have been possible without our local
partners and authorities. Thanks to the goodwill and assistance from these groups during the
first phase, we are now in a better position to continue expanding our medical development
in Zhuhai and hopefully also to other parts of China.”
Mr. Tan Hui Meng, Chairman of Singapore-based Rich Tree Group, said, “Zhuhai is on the cusp
of exponential growth as the FTZ continues to encourage both local and foreign investments.
The Zhuhai-Singapore Life Science Park is set to bring quality global healthcare to Southern
Forpersonaluseonly

2. Page 2 of 3
China, meeting the increasing demand for premium wellness treatments. It is truly exciting to
see the future of China’s medical industry come to fruition through this project.”
Mr. Charles E. Bogosta, Executive Vice President of UPMC and President of UPMC
International, said, “We are pleased to strengthen our long-term partnership with AAMG
through what will be a landmark project in China. With AAMG’s leadership and UPMC’s
clinical and technological expertise, this project will set new standards for medical care in
China and beyond.”
– END OF PRESS RELEASE –
About Asian American Medical Group
Asian American Medical Group (“AAMG”) is based in Singapore and has been listed on the
Australian Securities Exchange since September 2009. The Group’s operations include the
Asian American Liver Centre Pte Ltd (“AALC”), established in 1994 in Singapore, and Asian
American Radiation Oncology Pte Ltd (“AARO”).
The Group entered into a strategic collaboration in October 2012 with the US-based US$12-
billion integrated global health enterprise UPMC. UPMC, ranked No. 13 on the U.S. News &
World Report Honor Roll of American’s Best Hospitals, is affiliated with the University of
Pittsburgh Schools of the Health Sciences and are pioneers in the field of transplantation. This
collaboration has enhanced AAMG’s clinical capabilities through shared protocols, rigorous
quality standards and technology and also created a platform for AAMG to expand into other
countries in Asia such as Malaysia, Myanmar, China and Russia.
AALC, one of Asia’s foremost liver centres, is led by renowned hepatobiliary and liver
transplant surgeon, Dr. Tan Kai Chah (Dr. KC Tan), who helped start the Liver Transplant
Programme at the King’s College Hospital London, UK, and pioneered the highly successful
Living Donor Liver Transplantation (LDLT) Programme in Singapore.
AARO, established in March 2015, offers radiation oncology consultancy and management
and is spearheaded by Dr. Daniel Tan Yat Harn. Based in Singapore, AARO will drive expansion
into the growing radiotherapy and oncology segment in the overseas market, at a time where
there is a shortage of modern radiotherapy treatment centres.
For further information, please visit www.aamg.co.
Forpersonaluseonly

3. Page 3 of 3
About Rich Tree Holdings
Rich Tree Holdings (“RTH”) is a Singapore-incorporated and privately held investment holding
company. As part of the Rich Tree Group, RTH’s investments focus on real estate development
in Greater China and Southeast Asia, including the development of the Zhuhai-Singapore Life
Science Park in Zhuhai, Guangdong Province.
The conceptualisation and development of the Park will be carried out by Rich Tree Land Pte
Ltd (“Rich Tree Land”), a wholly-owned subsidiary of RTH, in collaboration with AAMG.
Besides Rich Tree Land, RTH has two wholly-owned foreign enterprises in China.
Media enquiries
WeR1 Consultants
Ms Rachael De Foe; rachaeldefoe@wer1.net
Tel: +65 6737 4844
Forpersonaluseonly